Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0057 | 0.0079 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0057 | 0.0455 |
Entamoeba histolytica | protein kinase, putative | 0.0575 | 0.1252 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.003 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0057 | 0.0221 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0057 | 0.0221 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1197 | 0.2681 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.003 | 0.0112 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.003 | 0.0239 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.003 | 0.0239 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0575 | 0.1252 | 0.4672 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0575 | 0.1252 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Echinococcus granulosus | protein kinase shaggy | 0.0575 | 0.1252 | 1 |
Brugia malayi | beta-lactamase | 0.0043 | 0.003 | 0.0041 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.003 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.003 | 0.0041 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0575 | 0.1252 | 1 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0575 | 0.1252 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.003 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.003 | 0.0112 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0057 | 0.0221 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0575 | 0.1252 | 0.4672 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.003 | 0.0041 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.003 | 0.0112 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.0569 | 1 |
Brugia malayi | intracellular kinase | 0.0575 | 0.1252 | 0.1727 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0575 | 0.1252 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0057 | 0.0221 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0575 | 0.1252 | 0.4672 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.003 | 0.5 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0575 | 0.1252 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.003 | 0.0112 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0575 | 0.1252 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0057 | 0.0221 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.1197 | 0.2681 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.003 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.003 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0575 | 0.1252 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.003 | 0.0112 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.003 | 0.0112 |
Onchocerca volvulus | 0.0575 | 0.1252 | 0.1226 | |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.1197 | 0.2681 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.1197 | 0.2681 | 1 |
Leishmania major | telomerase reverse transcriptase, putative | 0.1197 | 0.2681 | 1 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.1197 | 0.2681 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.003 | 0.5 |
Echinococcus multilocularis | protein kinase shaggy | 0.0575 | 0.1252 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0057 | 0.0221 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0575 | 0.1252 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0575 | 0.1252 | 0.4672 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0575 | 0.1252 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0575 | 0.1252 | 0.4672 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0057 | 0.0221 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.003 | 0.0041 |
Brugia malayi | Telomerase reverse transcriptase | 0.3184 | 0.7249 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.003 | 0.0239 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1197 | 0.2681 | 1 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0575 | 0.1252 | 0.4672 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.1197 | 0.2681 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.